Tempest Therapeutics Inc (TPST): TPST...$1.50s clearing into the close......

S&P 500

US TECH 100

Dow Jones

Brent Oil

Bitcoin

News Focus

News Focus

Tempest Therapeutics Inc (TPST)

Keep Last Read

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	2370
Posts	118410
Boards Moderated	0
Alias Born	12/17/2011

Re: None

Tuesday, 09/17/2024 3:57:04 PM

Tuesday, September 17, 2024 3:57:04 PM

TPST...$1.50s clearing into the close...🥳

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

1D
1M
3M
6M
1Y
5Y

Detailed Quote

Recent TPST News

Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/29/2026 09:06:06 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/29/2026 09:01:10 PM
Tempest Therapeutics Announces Warrant Exercise for Approximately $2 Million in Gross Proceeds • GlobeNewswire Inc. • 05/29/2026 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 09:28:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/22/2026 09:05:53 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 09:03:49 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:28:56 PM
Tempest Reports First Quarter 2026 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/14/2026 08:15:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2026 11:45:44 AM
Tempest Presents Clinical Update at ISCT 2026 Annual Meeting • GlobeNewswire Inc. • 05/06/2026 11:00:00 AM
Tempest to Advance Dual-Targeting CAR-T Platform with Clinical Update at ISCT 2026 Annual Meeting • GlobeNewswire Inc. • 04/29/2026 12:00:00 PM
Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T • GlobeNewswire Inc. • 04/22/2026 12:00:00 PM
Tempest Appoints Andrew Fang, Ph.D., as Head of Business Development to Advance Strategic Partnerships and Global Licensing Efforts • GlobeNewswire Inc. • 04/14/2026 12:00:00 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/10/2026 01:25:54 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 04/10/2026 01:24:42 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/10/2026 04:15:15 AM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 09:00:36 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 04/02/2026 01:50:03 AM
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 03/31/2026 10:01:25 AM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 03/30/2026 09:57:12 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 03/30/2026 09:55:59 PM
Tempest Reports Year End 2025 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/30/2026 01:00:00 PM

More TPST News

InvestorsHub community

Register for free to join our community of investors and share your ideas

You'll also get access to streaming quotes, interactive charts, trades, portfolio, live options flow